This week's award winners
Bill and Hillary Rodham Clinton liquidated the contents of their blind trust upon learning it contained investments of $5 million to $25 million that could pose conflicts of interest or prove to be embarrassing to her presidential campaign....
... The blind trust held stock in pharmaceutical companies, including $250,000-$500,000 in Biogen Idec and Johnson & Johnson and $100,000- $250,000 in Amgen, Pfizer and GlaxoSmithKline. It also invested in General Electric and Raytheon, two leading defense contractors. The trust had a varied portfolio, with investments in numerous other companies, including Exxon Mobil, BP Amoco, Walt Disney and eBay.